Michelle Abou-Jaoude
Quick facts
Marketed products
- K8 · Oncology
K8 is a monoclonal antibody that targets the PD-1 receptor.
Phase 1 pipeline
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: